Lee Terry Bacheler

Title: Lee Terry Bacheler: Innovator in Nucleic Acid Assays

Introduction

Lee Terry Bacheler is a notable inventor based in Newark, DE (US), recognized for his contributions to the field of nucleic acid assays. With a total of two patents to his name, Bacheler has made significant advancements in methods for evaluating nucleic acids.

Latest Patents

Bacheler's latest patents include a "Rapid, high capacity nucleic acid based assay." This invention describes a rapid method using chaotropic agents for evaluating nucleic acids. The assay allows for the detection and quantification of nucleic acid levels and can also serve as an infectivity assay or to evaluate the activity of anti-infectious agents. Another significant patent is related to "Stable human cell lines expressing an indicator gene product." This invention involves stable mammalian cell lines that integrate two heterologous DNA sequences, enabling the expression of desired proteins in response to regulatory proteins.

Career Highlights

Throughout his career, Bacheler has worked with prominent companies such as DuPont Merck Pharmaceutical and E.I. du Pont de Nemours and Company. His work in these organizations has contributed to the development of innovative solutions in the pharmaceutical and biotechnology sectors.

Collaborations

Bacheler has collaborated with notable colleagues, including Blair Q. Ferguson and Stephen R. Petteway. These partnerships have likely enhanced the scope and impact of his inventions.

Conclusion

Lee Terry Bacheler's work in nucleic acid assays showcases his innovative spirit and dedication to advancing scientific research. His patents reflect significant contributions to the field, and his collaborations further emphasize the importance of teamwork in achieving groundbreaking results.